Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema - Wikidata - awgldk - TriplyDB

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

http://www.wikidata.org/entity/Q24188127

about

Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects.Nonbiological pharmacotherapies for the treatment of diabetic macular edema.

P2860

Q36379507-ADCD2ABF-78F7-4C35-B288-9CD6249FD81E Q38622256-FFC0E8D8-9AD8-419B-8866-9ED8B165576E

P2860

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

http://www.wikidata.org/entity/Q24188127

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@ast

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@en

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@en-gb

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@nl

type

label

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@ast

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@en

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@en-gb

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@nl

prefLabel

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@ast

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@en

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@en-gb

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@nl

P1433

Q24188127-9349BC95-389C-405F-9BDA-A8F1AFCDF00C

P1476

Q24188127-060B619E-C84D-4EF1-9A10-40214549DDA4

P2093

Q24188127-17D70FF1-0F63-4C0A-B1ED-C8E7B217FB4A

Q24188127-1D33409D-D368-461B-9619-DD9077CAF746

Q24188127-8787E4E9-B0A2-4DF6-B942-A50EF3273BE9

Q24188127-94120D06-024C-46F6-AF75-2F1C89D904C6

Q24188127-9CB7176A-8F46-4D67-B45D-EFF539338922

Q24188127-CB982730-AD1D-4DF0-8040-B43AA8B2E577

P2860

Q24188127-1DD48192-F598-42FA-899A-0F9F96C50057

Q24188127-1F84C505-F803-426E-8A4F-26EE0F502578

Q24188127-25178A6B-61B4-4145-807D-6D4A26376673

Q24188127-27C060A8-37F2-4228-9D8E-E6BA0E79E768

Q24188127-3D9A2FF0-B2D2-4701-8081-946A904CF17F

Q24188127-3DABA002-6F3F-4A4F-9536-56B1246002EC

Q24188127-55B14FC5-0625-4B76-B128-9511EAF0D752

Q24188127-6576ECEB-9B9E-4292-9704-982B22934ADD

Q24188127-6ABCD44F-76B1-4E8F-8F1B-D821764CC5D1

Q24188127-726CF041-B12B-42FF-9CF3-4837A7E5644B

P31

Q24188127-98B744B5-7799-4684-8BCA-1488FE36B296

P356

Q24188127-BF71FFD4-9F23-48D8-BC1A-73B170B4B683

P577

Q24188127-73CA4ADE-BFF7-4E57-982E-50C467CF8931

P698

Q24188127-093164FB-DAF0-47A7-B95C-1D9EC08B1996

P356

14651858.CD010009.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

@en

P2093

Adinegara BL Abas

http://www.w3.org/2001/XMLSchema#string

Adnaan Haq

http://www.w3.org/2001/XMLSchema#string

Ankur Barua

http://www.w3.org/2001/XMLSchema#string

Kay Thi Myint

http://www.w3.org/2001/XMLSchema#string

N S Nair

http://www.w3.org/2001/XMLSchema#string

Soumendra Sahoo

http://www.w3.org/2001/XMLSchema#string

P2860

Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema

Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery

Intravitreal steroids for macular edema in diabetes

Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity.

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Diabetic macular oedema: a clinical overview.

Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.

Intravitreal injection of commercially available ketorolac tromethamine in eyes with diabetic macular edema refractory to laser photocoagulation.

Prostaglandins and cystoid macular edema.

Diabetic retinopathy: more than meets the eye.

P31

scholarly article

P356

10.1002/14651858.CD010009.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25686158

http://www.w3.org/2001/XMLSchema#string